US biotech Kailera Therapeutics has reported positive top-line data from two Chinese Phase III studies of HRS-7535, an oral small-molecule GLP-1 receptor agonist it is developing outside Greater China ...

French genetic medicines company Cyllene Therapeutics has raised 33 million euros ($38 million) in series C financing to ...

Florida, USA-based clinical-stage biopharma DemeRx has appointed Michael Snitkovsky as chief operations officer, adding a ...

French inflammatory diseases specialist Abivax yesterday announced the closing of its previously announced underwritten ...

France-based life sciences venture capital firm Sofinnova today announced that its portfolio company Myricx Bio has reached ...

Codis has agreed to acquire Catalent Pharma Solutions’ Nottingham, UK, facility, expanding its contract development and manufacturing organization (CDMO) capabilities in oral solid dose development ...

M&A was again a big feature in last week's news, with AbbVie’s acquisition of Apogee Therapeutics, along with its atopic ...

AlzeCure Pharma has signed an out-licensing and collaboration agreement with Denmark’s privately held QuantumCell, granting ...

US biotech Viridian Therapeutics saw its shares climb more than 10% to $19.81 in after-hours activity Friday, when it ...

India’s pharmaceutical industry is witnessing a surge in global partnerships, with countries such as Switzerland, Uzbekistan, ...

Danish biotech company Muna Therapeutics has named Michel Detheux as chief executive as it prepares to move its lead ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Keytruda (pembrolizumab), within ...